Improving cancer drug development for diverse populations
Official title: Research Education
Funded at University of California Riverside · NIH-10933481 · Data updated 2026-11-12
This study is working to make cancer treatments better for everyone by encouraging more Latino/Hispanic and African-American people to get involved in cancer research, so that the next generation of researchers truly represents the diverse communities in Southern California.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Riverside NIH-funded |
| Lab location | 1 site (Riverside, United States) |
| Project start | September 22, 2023 |
| Project end | August 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $124,188 |
| NIH project number | 5U54CA285114-02 |
| Project ID | NIH-10933481 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include Latino/Hispanic-American and African-American individuals affected by cancer.
✕Less likely to help
Patients who do not identify as Latino/Hispanic-American or African-American may not receive direct benefits from this research.
What this research studies
This research aims to address the disparities in cancer drug development that predominantly favor European-Americans by enhancing the participation of Latino/Hispanic-American and African-American communities. The project focuses on building a collaborative research education core between the University of California at Riverside and the City of Hope Comprehensive Cancer Center. It will develop training programs and research infrastructure to cultivate a new generation of therapeutics researchers who reflect the ethnic diversity of Inland Southern California. By integrating research experiences and educational outreach, the initiative seeks to ensure that future cancer treatments are more inclusive and effective for all populations.
Why it matters
Potential benefit: If successful, this research could lead to more effective cancer treatments tailored to the needs of diverse populations.
How similar studies have gone: Other research initiatives have shown success in addressing health disparities through community engagement and inclusive research practices.
Where this research is happening
-
University of California Riverside
Riverside, United States Active
Researchers
- Principal investigator: Pellecchia, Maurizio — University of California Riverside
- Study coordinator: Pellecchia, Maurizio
Related research
Other NIH-funded projects on the same topics.
-
Cellular programming by plant signaling in cancer and other diseases
Scientists are studying how plant cell signals control gene activity in the nucleus and mitochondria to understand faulty regulation that can occur in cancers and other disorders.
-
Caveolin-1 helps brain vessels stay healthy after juvenile concussion
A study in kids and young adults looks at how a protein called Caveolin-1 affects brain blood vessels after a mild concussion and whether targeting it could protect long-term brain health.
-
How tiny cell antennae control signals linked to birth defects and cancer
Researchers are looking for new proteins in cells' tiny antennae that control signals involved in certain birth defects and cancers to point toward future treatments.
-
New ways to make natural compounds that could fight cancer, Alzheimer's, and inflammation
A scientist team will make and test natural-looking molecules to see if they can block proteins linked to cancer, Alzheimer's disease, and inflammatory conditions.
-
Promoting Coping Skills to Reduce Health Gaps in Teens and Young Adults
A study tests a shift-and-persist coping approach to help racial/ethnic minority teens and young adults handle stress and reduce risks for chronic disease.
-
Laser particle barcoding to track live cells and their omics in breast cancer
A new technique uses special laser-coded particles to follow individual breast cancer cells in real time while linking their live behavior to multi-omics data.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.